Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 69 of 1,261
  1. US 12194138

    Devices and methods for delivering therapeutics

    Vertex Pharmaceuticals Incorporated Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  2. US 12194091

    Antibodies that bind human C6 and uses thereof

    REGENESANCE B.V. Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  3. US 12194078

    Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant

    Cartesian Therapeutics, Inc. Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  4. US 12195439

    C1-substituted isopropylamine fused heterocyclic mescaline derivatives

    Enveric Biosciences Canada Inc. Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  5. US 12195535

    Antibodies binding to VISTA at acidic pH

    Five Prime Therapeutics, Inc. Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  6. US 12194079

    Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosidase

    Protalix Ltd. Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  7. US 12195454

    Compounds for imaging tau proteins that accumulate in the brain

    National Institutes for Quantum and Radiological Science and Technology Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  8. US 12194065

    Methods and compositions to enhance metabolic detoxification systems

    Nature's Sunshine Products, Inc. Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  9. US 12195766

    Tumor-selective E1a and E1b mutants

    The Regents of the University of California Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  10. US 12195453

    Antiproliferation compounds and uses thereof

    Vertex Pharmaceuticals Incorporated Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  11. US 12195768

    System and method for modulating stress granule assembly

    THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  12. US 12194082

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  13. US 12194049

    Composition for treating carbapenem antibiotic-resistant Acinetobacter baumannii infection

    GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  14. US 12194090

    Tetanus vaccine platform for embedding COVID-19 vaccine

    Prime Bio, Inc. Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  15. US 12194059

    Compositions comprising citrate and applications thereof

    The Board of Regents of the University of Texas System Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  16. US 12194064

    Process of producing concentrated therapeutic phospholipid composition from krill extracts containing high level of free fatty acids

    Aker BioMarine Human Ingredients AS Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  17. US 12195447

    Azolopyrimidine for the treatment of cancer-related disorders

    Arcus Biosciences, Inc. Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  18. US 12194150

    Levodopa dosing regimen

    AMNEAL PHARMACEUTICALS LLC Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  19. US 12194084

    Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses

    Northwestern University Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  20. US 12194061

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  21. US 12194081

    ARGINASE1 polypeptides

    IO Biotech ApS Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  22. US 12194016

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. Β· Granted Jan 14, 2025 Β· Expires Jan 9, 2045

    granted
  23. IT 202300014295

    COMPOSIZIONI ORODISPERSIBILI COMPRENDENTI BETAMETASONE FOSFATO

    ALFASIGMA SPA [IT] Β· Granted Jan 12, 2025 Β· Expires Jan 7, 2045

    granted
  24. US 12186406

    Materials and methods for treatment of hereditary haemochromatosis

    CRISPR THERAPEUTICS AG Β· Granted Jan 7, 2025 Β· Expires Jan 2, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.